Post-transplant cyclophosphamide for GVHD prophylaxis in pediatrics with chronic active Epstein-Barr virus infection after haplo-HSCT
Rongmu Luo(Aerospace Center Hospital), Jingbo Wang(Aerospace Center Hospital), Zhengqin Tian(Aerospace Center Hospital), Qihang Man(Aerospace Center Hospital), Ya Wang(Wenzhou Medical University), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Wenjing Gu(Aerospace Center Hospital)
Cited by 5
Related Papers
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Extracellular Histones Are Mediators of Death through TLR2 and TLR4 in Mouse Fatal Liver Injury
|The Journal of Immunology|2011|522
A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models
|Cancer Research|2013|485
Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state
|Science Translational Medicine|2019|316